Investing.com - Financial Markets Worldwide

Saba Capital sells $474,961 in abrdn Life Sciences Investors stock

Published 31/03/2025, 17:18
Saba Capital sells $474,961 in abrdn Life Sciences Investors stock
HQL
0.69%

In recent transactions, Saba Capital Management, L.P., a significant shareholder of abrdn Life Sciences Investors (NYSE:HQL), reported selling shares of the company. The stock, currently trading at $12.54, offers a notable 14.6% dividend yield and has maintained dividend payments for 30 consecutive years, according to InvestingPro data. The firm, led by Boaz Weinstein, disclosed the sale of a total of 36,524 shares over two days, March 27 and March 28, 2025. The shares were sold at prices ranging from $12.95 to $13.01, amounting to a total transaction value of $474,961.

Following these transactions, Saba Capital holds 3,237,028 shares of abrdn Life Sciences Investors. The sales were executed as part of regular trading activities and reflect Saba Capital’s ongoing management of its investment portfolio.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.